 | Up a level |
2021
Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., Peters, S., Hong, Y-K, Winkler, F., Schadendorf, D., van den Bent, M., Seoane, J., Stahel, R., Minniti, G., Wesseling, P., Weller, M. and Preusser, M. (2021). EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann. Oncol., 32 (11). S. 1332 - 1348. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2020
Franklin, C., Wetter, A., Baba, H. A., Cosgarea, I., Mauch, C., Livingstone, E., Zimmer, L., Schadendorf, D. and Ugurel, S. (2020). The diagnostic Significance of CT-controlled Puncture in Skin Cancer Patients. J. Dtsch. Dermatol. Ges., 18. S. 27 - 28. HOBOKEN: WILEY. ISSN 1610-0387
Livingstone, E., Zaremba, A., Horn, S., Ugurel, S., Casalini, B., Schlaak, M., Hassel, J. C., Herbst, R., Utikal, J. S., Weide, B., Gutzmer, R., Meier, F., Koelsche, C., Hadaschik, E., Sucker, A., Reis, H., Merkelbach-Bruse, S., Siewert, M., Sahm, F., von Deimling, A., Cosgarea, I., Zimmer, L., Schadendorf, D., Schilling, B. and Griewank, K. G. (2020). GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. Br. J. Dermatol., 183 (5). S. 928 - 940. HOBOKEN: WILEY. ISSN 1365-2133
Zaremba, A., Martaki, A., Salzmann, M., Baroudjian, B., Sachse, M. M., Gesierich, A., Reinhardt, L., Meier, F., Hassel, J. C., Ugurel, S., Roesch, A., Schadendorf, D., Livingstone, E., Broeckelmann, P., Kramer, R., Heinzerling, L. and Zimmer, L. (2020). Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation. J. Dtsch. Dermatol. Ges., 18. S. 15 - 17. HOBOKEN: WILEY. ISSN 1610-0387
2017
Cosgarea, I, Zimmer, L., Weide, B., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pfoehler, C., Gesierich, A., Herbst, R., Kaehler, K., Schlaak, M., Loquai, C., Utikal, J., Kaatz, M., Berking, C., Kreuter, A., Ulrich, J., Mohr, P., Dippel, E., Livingstone, E., Weichenthal, M., Schadendorf, D. and Ugurel, S. (2017). Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients. J. Dtsch. Dermatol. Ges., 15. S. 16 - 18. HOBOKEN: WILEY. ISSN 1610-0387
2016
Hassel, J., Forschner, A., Bluhm, L., Heinzerling, L., Zimmer, L., Utikal, J., Kaehler, K., Schlaak, M., Loquai, C., Gutzmer, R., Kieker, F., Berking, C., Bender, A., Schneider, L., Enk, A., Garbe, C., Weichenthal, M., Schadendorf, D., Hauschild, A. and Mohr, P. (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Dtsch. Dermatol. Ges., 14. S. 9 - 10. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
2014
Kordelas, L., Verheyen, J., Beelen, D. W., Horn, P. A., Heinold, A., Kaiser, R., Trenschel, R., Schadendorf, D., Dittmer, U. and Esser, S. (2014). Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation. Oncol. Res. Treat., 37. S. 38 - 39. BASEL: KARGER. ISSN 2296-5262
2010
Hassel, J. C., Sucker, A., Edler, L., Kurzen, H., Moll, I., Stresemann, C., Spieth, K., Mauch, C., Rass, K., Dummer, R. and Schadendorf, D. (2010). MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br. J. Cancer, 103 (6). S. 820 - 827. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827